期刊文献+

EPHB6受体型酪氨酸蛋白激酶对ERK信号通路的调控效应 被引量:2

Regulation of EPHB6 receptor tyrosine kinase on the ERK signaling pathway
下载PDF
导出
摘要 目的:探讨促红细胞生成素产生肝细胞B6(EPHB6)对于胞外信号调节激酶(ERK)信号转导通路的作用.方法:以非小细胞肺癌细胞系A549作为研究对象,采用Western Blot法检测ERK的磷酸化水平及通路检测(PathDe-tect)法检测ERK下游分子和Ets结构域蛋白1(Elk-1)转录因子的活性.结果:A549细胞中EPHB6的表达导致ERK的磷酸化.相反,siRNA干涉EPHB6的表达可以逆转ERK的磷酸化.并且,EPHB6导致的ERK磷酸化与Elk-1转录因子脱偶联.结论:表明EPHB6对于ERK信号通路具有调控作用. AIM:To investigate the regulatory effects of EPHB6 receptor tyrosine kinase on the signaling pathway of ERK MAPK.METHODS:A549 non-small cell lung cancer cell line was used in the experiments.Western blotting was used to assess the phosphorylation levels of EPHB6,and the status of Elk-1,a transcriptional activator downstream of EPHB6,was determined by PathDetect kit.RESULTS:Expression of EPHB6 induced the expression knocking-down by EPHB6 siRNA of ERK in A549 cells.reversed the phosphorylation of ERK.Moreover,EPHB6-induced phosphorylation of ERK was uncoupled with Elk-1 transcriptional activator.CONCLUSION:EPHB6 plays a role in the regulation of ERK signaling pathway.
出处 《第四军医大学学报》 北大核心 2009年第19期1864-1867,共4页 Journal of the Fourth Military Medical University
基金 国家自然科学基金(30801385)
关键词 EPHB6 受体型酪氨酸蛋白激酶 非小细胞肺癌 细胞外信号调节激酶 有丝分裂原蛋白活化激酶 Elk-1 NSCLC non-small cell lung cancer MAPK mitogen-activated protein kinase ERK extracellular-signal-regulated kinase DMSO dimethylsulfoxide FACS fluorescence-activated cell sorting
  • 相关文献

参考文献1

  • 1Hadara Rubinfeld,Rony Seger. The ERK cascade[J] 2005,Molecular Biotechnology(2):151~174

同被引文献23

  • 1李旭桂,王广发,张俊艳,吴少瑜,徐伟,吴曙光,张嘉杰.用于蛋白酪氨酸激酶抑制剂高通量筛选的均相时间分辨荧光免疫方法的建立[J].南方医科大学学报,2009,29(8):1612-1614. 被引量:3
  • 2Fox BP,Kandpal RP.EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells[J].Oncogene,2009,28:1706-1713.
  • 3Sjoblom T,Jones S,Wood LD,et al.The consensus coding sequences of human breast and colorectal cancers[J].Science,2006,314:268-274.
  • 4Boudeau J,Miranda-Saavedra D,Barton GJ,et al.Emerging roles of pseudokinases[J].Trends Cell Biol,2006,16:443-452.
  • 5Luo H,Yu G,Tremblay J,et al.EphB6-null mutation results in compromised T cell function[J].J Clin Invest,2004,114:1762-1773.
  • 6Jemal A,Siegel R,Ward E.Cancer Statistics[J].CA Cancer J Clin,2009,59:225-249.
  • 7van Zandwijk N,Mooi WJ,Rodenhuis S.Prognostic factors in NSCLC.Recent experiences[J].Lung Cancer,1995,12(Suppl 1):S27-33.
  • 8Ansari J,Palmer DH,Rea DW,et al.Role of tyrosine kinase inhibitors in lung cancer[J].Anticancer Agents Med Chem,2009,9:569-575.
  • 9Santos ES,Blaya M,Raez LE.Gene expression profiling and non-small-cell lung cancer:where are we now[J].Clin Lung Cancer,2009,10:168-173.
  • 10Menzel P,Valencia F,Godement P,et al.Ephrin-A6,a new ligand for EphA receptors in the developing visual system[J].Dev Biol,2001,230:74-88.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部